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Abstract
Many patients suffering from peripheral arterial occlusive disease (PAOD) experience
intermittent claudication, pain during locomotion. Previous studies suggest that this
symptom could be explained in part by impaired vasodilation in collateral arteries. In this
study, femoral ligation was performed on a murine animal model, stimulating collateral
outward remodeling. The mechanism by which a collateral increases its luminal diameter
in response to the increase in blood flow following occlusion warrents further
investigation due to impaired vasodilation following collateral remodeling. Specifically,
resting diameter is elevated in the stem region of the collateral circuit, but this increase in
vessel size cannot be explained by vascular smooth muscle cell (VSMC) proliferation.
Therefore, we tested the hypothesis that enlargement was due to changes in VSMC
overlap and/or length, a process known as mechanoadaptation. VSMC length and overlap
measurements in the profunda femoris were taken from 40x confocal images. Mean
VSMC length and overlap were measured 7 and 28 days post ligation. Mean length was
222 µm ± 76 vs 229 µm ±12 in the contralateral control limb and 310 µm ± 67 vs 187
µm ± 31 in the contralateral control limb, respectively. Overlap was 23 ± 2 vs 27 ± 2 in
the contralateral control limb and 30 ± 5 vs 30 ± 3 in the contralateral control limb,
respectively. None of the values were significantly different. A major challenge faced
included the inability of the vessel to maintain their native cylindrical shape because of
the way they were flattened during storage on the microscope slides. A proposed
perfusion fixation technique with 4% paraformaldehyde may allow for the excised
muscle to maintain its native geometry and more VSMC overlap measurements to be
taken.
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CHAPTER 1
Introduction to Ischemic Disease
Ischemic disease manifests as different pathologies depending on the vascular bed
affected, including peripheral arterial occlusive disease (PAOD). The build up of
atherosclerotic plaque results in increased blood flow and arterial wall shear stress in
collateral vessels, connections that functiona as anastomoses and provide a natural bypass
for blood around the occlusion (Figure 1). These collaterals can partially restore oxygen
delivery and meet the metabolic demand of the downstream tissue. Patients diagnosed
with PAOD experience locomotion-induced pain, referred to as intermittent claudication,
which restricts their exerise tolerance and negatively affects their quality of life [6]. In the
absence of well-developed collaterals, tissue downstream of an occlusion can be
reperfused by stenting and angioplasty. Although these options are generally effective,
they are not always a practical solution.

Figure 1 Vascular Occlusion. An occlusion in peripheral arteries causes a re-routing of
blood, often accompanied by a structural enlargement of those vessels now supporting a
larger flowrate [4].
Angioplasty includes the insertion of a balloon catheter via the femoral artery,
which is deployed and inflated at the site of the narrowed lumen. The balloon pushes the
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plaque against the vascular wall and flattens it. Angioplasty is not a feasible therapy for
patients suffering from PAOD due to the fact that 30-50% of recipients experience a renarrowing of the blood vessel, called restenosis, some time after the procedure [2]. Over
50% of coronary artery angioplasty recipients experienced post-angioplasty restenosis,
suggesting that additional revascularization measures are necessary

to decrease the

probability of restenosis [11]. Another alternative treatment is stenting. A stent is a
cylindrical medical device made out of woven metal wire, often Cobalt –Chromium,
Stainless Steel, or Nitinol and is inserted via a femoral artery catheter. The stent is
deployed at the area of occlusion, exerting a constant force against the vascular wall,
which flattens the plaque. Eventually, endothelialization, the growth of endothelium over
the surface of the device, establishes a new layer of cells over the stent. Stenting is
sometimes not a feasible option for patients with PAOD because with the implantation of
most medical deivces, there poses a large risk for thrombosis [6]. Particularly with regard
to drug-eluting students, in which late-stent thrombosis is not uncommmon, a lower
perfusion rate was observed in patients with late-stent thrombosis [12].
If PAOD is left untreated, and if sufficient collateral vessels are not present,
hypoxic conditions may result in tissue necrosis. Limb amputation is a last resort, as it
drastically reduces a patients quality of life. Due to the issues with these two possible
treatments for patients suffering from PAOD, there is a need for an alternate therapy.
Humans have collateral vessels withing their circulatory system, which serve to
optimize tissue perfusion. When atherosclerotic plaques reduces the ability of the
vasculature to meet metabolic oxygen demands, collaterals can function as natural bypass
routes. When an occlusion occurs, these collateral vessels have blood flow redirected into
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them. For optimum collateral function, they must be capable of vasodilation.
Unfortunately, that the enlargement processes following this redirection of blood flow
into collaterals is accompanied by impaired vasodilation. Further knowledge regarding
this mechanism of impairment is an essential step in the development of angiogenic
therapies.
Arterial vasodilation is necessary for oxygen and nutrient delivery to tissue. This
phenomenon increases a PAOD patient’s risk of intermittent claudication which is a
motivation behind this study. More specifically, the purpose of this study is to observe
the remodeling response stimulated by collateral enlargement and its effect on vascular
wall behavior.
Previous work (unpublished observations) indicates that collateral enlargement
impairs vasodilation. However, because VSMC proliferation was no observed in this
region of the collateral circuit (the stem), the mechanism of impaired vasodilation is
unclear. Therefore, we hypothesize that smooth muscle cells reorioent themselves to
account for the increase in vessel diameter, called mechanoadaptation, and that the
vasodilatory response is impaired during the reorientation process (Figure 2). Thus,
further studies are needed to test this hypothesis.
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Site of Ligation

Figure 2 Gracilis Muscle. A superficial view of a mouses hindlimb, its femoral artery,
site of ligation, and profunda femoris artery, which exhibits an increased resting diameter
and impaired vasodilation at day-7 following ligation.

Specific Aims
It is hypothesized that following femoral occlusion, the profunda femoris artery
will undergo structural enlargement by mechanoadaptation, achieved by decreases in
smooth muscle cell overlap (Figure 2). This mechanoadaptation is explored to determine
its role in the impairment of vasodilation mechanisms in collateral vessels. The results
from this study may explain some of the symptoms of ischemic disease. Developing a
protocol for imaging the vessels and measuring VSMC length and overlap will allow for
data analysis that will either support our hypothesis or not.
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Aim 1 – Protocol for imaging vessels
This experiment will test and validate the protocol for imaging excised gracilis
muscles. The current protocol involves the whole mounting of each specimen along with
mounting media onto glass microscope slides. Each slide is placed under fluorescent light
or a confocal laser for imaging.
Aim 2 – Measurement of VSMC length and overlap
Using an imaging software, cells will be randomized and measurements of their
length and overlap will be taken. According to G*Power Software, 5 cells from each
profunda will need to be measured in order to have a power value of 0.98. It should be
noted that although 5 is the suggested sample size, the flattened geometric nature of each
muscle may not allow for this many cells to be measured [17].

5

CHAPTER 2
Animal Model and Study Overview
The animal care protocol used in this study was approved by IACUC
(Institutional Animal Care and Use Committee). PAOD was modeled and collateral
enlargement was induced in eight C57Bl/6 mice aged 7-9 weeks by ligating the left
hindlimb femoral artery between the profunda femoris and popliteral artery-vein pairs. A
sham surgery was performed on the right hindlimb of each mouse. The left hindlimb
provided an animal model for PAOD and collateral enlargement while the right hindlimb
served as the control. Each muscle was stained for alpha smooth muscle actin in order to
view individual smooth muscle cells with fluorescent and confocal microscopy.
Microscopy
Post staining protocol involved the storage of 16 gracilis muscles in PBS. During
staining, the muscles were washed and stained with alpha smooth muscle actin for 3
nights at 4°C. After staining, each sample was mounted on a glass microscope slide in
preparation for fluorescent and confocal imaging. For all confocal images, a 40x oil
immersion objective was used with a numerical aperture of 0.75.
Morphometry
Mean cell and overlap lengths were measured with 3 different cells on each
profunda. The equations and methods used can be found in Appendix B.
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CHAPTER 3
Results
The goal of this study was to explore the extent which mechanoadaptation
explains impaired vasodilation. Analysis of confocal images of the profunda femoris
artery included measurement of cell overlap and individual cell length. Figure 3 is an
example of a 40x magnified confocal image of a profund
profunda sample.

Figure 3 Color Filter Applied to Vascular Smooth Muscle Cell Overlap. The
profunda femoris (A) and two magnified images of a wall segment with apparent cell
overlap. (B) has a red filter for improved visualization and (C) has been inverted for
distinction of the geometric boundaries of each cell.
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Figure 4 Smooth Muscle Cell Overlap. This is a magnified image of multiple instances
of smooth muscle cell overlap. Overlap length measurements were made using Equation
1 (Appendix C).
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Figure 5 Quantitative Extent of Smooth Muscle Cell Overlap
Overlap.. (A) shows the overlap
length as a percentage of vessel diameter 7 days post ligation. (B) shows the overlap
length as a percent
percentage
age of vessel diameter for mice 28 days post surgery.
Tables I and II below list the measured smooth muscle cell lengths, overlaps, and
their mean standard errors for control and ligated limbs, 7 and 28 days post ligation.
Table I: VSMC Length Data
Limb/Day
Control/7
Control/28
Ligated/7
Ligated/28

Cell Length (µm)
229
187
222
310

± MSE
12
31
76
67

Table II: VSMC Overlap Data
Limb/Day
Control/7
Control/28
Ligated/7
Ligated/28

Overlap Length (µm)
27
30
23
30

± MSE
2
3
2
5
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CHAPTER 4
Discussion
PAOD is a serious condition in which blood flow downstream of occluded vessels
is diminished. When a patient has collateral vessels, symptoms may be improved.
However, if these collaterals are not dilating properly, sufficient nutrient deliveriy to
dissues during increased metabolic demand may not be met. Moreso, intermittent
claudication, hypoxic pain with exercise or locomotion, decreases quality of life and
necessitates further investigation into the mechanism underlying impaired vasodilation.
Collateral enlargement was stimulated in a murine animal model to examine its impact on
vasodilatory ability. It was hypothesized that rearrangement of smooth muscle cells
would occur around the vessel’s circumference to change luminal diameter. This
mechanoadaptation could be a stimulus that contributes to the impairment of
vasodilation. It is aparent that one way that a collateral responds to changes in blood flow
is increasing or decreasing overlap between two or more individual cells. This
phenomenon is a positive change initially because metabolic demands of downstream
tissues may be met. However, when further vasodilation is necessary, the vessel is not
able to accommodate.
Rearrangement, consistent with our hypothesis, would result in a decrease in the
right hindlimb 7 days post ligation, and a return to control length 28 days post ligation.
Although this rearrangement was observed as well as a general trend, not enough
measurements were made due to poor muscle storage. A maximum of 4 measurements
were able to be made on each profunda but G*Power Analysis Statistical Software
suggests that 5 should be measured to increase the power of the experiment [17]. At 40x
magnification, each artery had not maintained its native cylindrical geometry. Therefore,
10

it would be helpful to use perfusion fixation of muscle tissue to maintain this geometry.
One recommendation involves perfusion fixation of tissue in vivo before the muscle is
excised. Insufficient fixation can be

due to a low perfusion pressure [13], so this

parameter must be carefully monitored during perfusion fixation. The addition of a 4%
paraformaldehyde perfusion fixation technique could allow for more measurements to be
taken. This would allow for a closer observation of impaired vasodilation and its effects
on collateral enlargement. If future experimentation that includes perfusion fixation
yields muscles that do not have strong enough fluorescence, antigen retrieval may be
necessary. Boiling each specimen in water should result in the presentation of antigens
which will yield a stronger fluorescence for functional microscopy and morphometry
measurements.
Further studies could also include those which stimulate mechanoadaptation
independent of arterial occlusion, so that the causal role of this process in impaired
vasodialtion could be evaluated. Results from this study could shed light on the exact
mechanism which impairs vasodilation in a collateral after structural remodeling has
occurred.
Overall, impaired vasodilation can explain some symptoms of ischemic disease,
which is the highest rated cause of mortality within the United States population. The
ability of the profunda femoris artery to vasodilate after collateral outward remodeling in
murine hindlimbs can shed light on the mechanism behind this impairment. Further
studies should include a perfusion fixation technique that maintains a vessel’s native
geometry paired with close observation during mechanoadaptation stimulation and
inhibition. This will effectively increase the statistical power of the experiment.
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Appendix A
Images of each profunda at 40x
(Figures 6-15)
LEFT DAY 7

RIGHT DAY 7
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LEFT DAY 7

RIGHT DAY 7
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LEFT DAY 7

RIGHT DAY 7
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LEFT DAY 28

RIGHT DAY 28
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LEFT DAY 28

RIGHT DAY 28
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Appendix B
Image Analysis and Geometric Characterization
Analysis of all images was performed using ImageJ software. Each z-stack
z
was
composed of 30, 30µm
µm
m slices. After opening the .tiff file in ImageJ, the segmented line
tool was used to obtain an accurate measurement of overlap length. To measure cell
length, the equation below was used.
Circumference=2*π
Circumference=2*π*Radius
Cell Length=Circumf
Length=Circumference - overlap length

Eq.1
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Appendix C
Methods
In order to model functional vasodilation, stimulation of th
thee gracilis muscle was
done in mice, activating endogenous vasodilation. After administration of anesthesia (5%
isofluorane), the surgical procedure began with the application of depilatory cream to
remove hair around the incision site. PBS was applied to the incision site to prevent tissue
dessecation. Blunt dissection of conn
connective
ective tissue was done to expose the gracilis muscle.
Two electrodes were placed on the muscle, which was stimulated for 90 seconds with
1mA at a frequency of 8Hz [10].
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Appendix D
Perfusion Fixation Background
The current protocol for imaging vessels does not allow the muscle to maintain its
cylindrical geometry which makes it difficult to image the vesel and see all of the cells.
The process of fixation stops biochemical reactions from progressing and strengthens the
physical stability of the tissue. Different types of fixation include heat, perfusion, and
immersion. Perfusion, relevant to this study, is fixation via the circulatory system. This is
done by injecting the fixation solution into the ventricles or aorta [15].
A perfusion fixation protocol in which 4% paraformaldehyde (PFA) is injected via
the abdominal aorta allows for the cessasion of biochemical reactions and leaves all
circulatory vessels fixed in their native geometry (Appendix D).
Fixation is a immunohistochemistry process that involves the digestion of enzymes. If
this digestion process is inefficient, antigen retrieval is necessary. Epitope retrieval, more
specifically, is achieved by heating the specimen in question. This process is called heat
induced epitope retrieval (HIER) [14]. The most common and effective method of HIER
is boiling the specimen in a buffer solution.

Perfusion Fixation Materials and Protocol (ABCAM)
Anaesthetic
Scissors, forceps, and clamps for surgical procedures
Small forceps with fine claws
Scalpel
Vials (5-10 ml) with lids for specimens
0.9% saline
500 ml beakers
4% paraformaldehyde, fixation solution
Gloves, eye goggles
Perfusion pump (or flask with fixative placed upside down about 150 cm above the
operating table)
Short syringe needle for heart perfusion of aorta, length about 50 mm, outer diameter 1.3
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- 1.5 mm
Perfusion set with drip chamber as used for intravenous blood infusions
Protocol (ABCAM)
Perfusion fixation through the abdominal aorta
1. Prepare materials and animal as stated above (steps 1-3).
2. Open the abdominal cavity by a long midline incision with lateral extension, and
move the intestines gently to the left side of the animal.
3. Carefully expose the aorta below the origin of the renal arteries and very gently
free the aorta from overlaying adipose and connective tissues.
4. Hold the wall of the aorta firmly with fine forceps with claws about 0.5 - 1.0 cm
from its distal bifurcation. Insert a bent needle close to the forceps towards the
heart into the lumen of the aorta.
5. In very rapid succession:
a) Cut a hole in the inferior caval vein with fine scissors,
b) Start the perfusion and
c) Clamp the aorta below the diaphragm, but above the origin of the renal arteries.
When performing these manipulations accuracy and speed are essential and the
fixation procedure is preferably carried out by two persons. It is particularly
important to clamp the aorta rapidly after the perfusion has been started. This is
most easily done by compressing the aorta toward the posterior wall of the
peritoneal cavity with a finger (wear gloves) which is then replaced by a clamp.
Finally, cut the aorta above the compression.
6. The kidney surface must blanch immediately and show a uniform, pale colour.
The flow rate should be at least 60-100 ml/min for an adult rat. Perfuse for 3 min.
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Stop the perfusion and excise and trim the tissues. Store the tissue in vials and
immersion-fix in the same fixative (post fixation step) for 2 hr on ice or at 4°C.
For better results, immersion-fix overnight at 4°C.
7. The tissue is now ready for dehydration and embedding [16].
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Appendix E
Method for calculating sample size and power analysis
Free software is available for G*Power Free Download at:
http://www.psycho.uni-duesseldorf.de/abteilungen/aap/gpower3/download-and-register/index_html

Enter in:
• Test family
• Statistical tests
• Type of power analysis
• Input parameters:
o Tails
o Effect size
o Alpha error probability
o Power (1-Beta)
Output is:
• Critical t
• Total sample size
• Actual power
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